In Depth 8 Apr 2024 A wave of biotech layoffs: will the trend continue throughout 2024? Thousands of jobs have been at risk over the past year due to mass layoffs by biotech companies across the globe. April 8, 2024 - 9 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 21 Mar 2024 Biotech in France: What’s holding back progress and how to move forward? Explore the latest insights from France Biotech’s ‘Panorama France HealthTech’ report, uncovering key insights of the French biotech sector. March 21, 2024 - 8 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 18 Mar 2024 Will the US biotech funding surge trigger a renaissance in the global biotech industry? After a couple of challenging years in biotech investment, the US leads the march for recovery. Delve into the specifics driving this uptick. March 18, 2024 - 10 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 6 Mar 2024 The biggest private biotech investments in February 2024 The companies BioAge Labs, Latigo Biotherapeutics, and Neurona Therapeutics bagged the biggest private biotech investments in February 2024. March 6, 2024 - 3 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Best in Biotech 5 Mar 2024 Fourteen biotech companies with market caps exceeding $100 billion Discover the biotech leaders with a market capitalization exceeding $100 billion, driving innovation and shaping tomorrow’s breakthroughs. March 5, 2024 - 18 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 9 Feb 2024 Biotech job market 2024: what to expect? The past year saw pipeline cuts and downsizing plans strike the biotech industry. Does the biotech job market seem to be looking up this year? February 9, 2024 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 7 Feb 2024 The biggest private biotech investments in January 2024 Jixing Pharmaceuticals, COUR Pharmaceuticals, and OnCusp Therapeutics bagged the biggest private biotech investments in January 2024. February 7, 2024 - 2 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 10 Jan 2024 The biggest private biotech investments in December 2023 The companies Tome Biosciences, Bicara Therapeutics, and Seismic Therapeutic bagged the biggest biotech investments in December 2023. Around the world, food, immunology, oncology, central nervous system (CNS), and biofermentation players attracted the biggest funding rounds overall. Although December is generally a quiet time for biotech fundraising, there were still some big rounds raised in the […] January 10, 2024 - 3 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Opinion 18 Dec 2023 What to expect from biotech clinical trials in the coming year As cancer research has seen an increase in funding lately, here are some of the key clinical trends that you can expect in 2024. December 18, 2023 - 11 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
In Depth 7 Dec 2023 The biggest private biotech investments in November 2023 The companies Cambrian Innovation, Terremoto Biosciences, and VectorY Therapeutics bagged the biggest biotech investments in November 2023. Around the world, oncology and central nervous system players attracted the biggest funding rounds. As we edge closer to Christmas, biotech fundraising appears to be drying up a bit; there was a significant decrease in funding rounds in […] December 7, 2023 - 3 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 20 Nov 2023 M&As: what’s up with the ADC buying spree? Antibody drug conjugates (ADCs) have been much sought-after through investments of late, with big pharma eyeing these drugs developed by various biotechs, to eventually nab them. With yet another ADC being bought by Bristol Myers Squibb, and AbbVie’s proposed $10 billion deal to seize ImmunoGen’s oncology pipeline, are these drugs the golden ticket to targeted […] November 20, 2023 - 7 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 17 Nov 2023 With $700 million Q3 rise, U.K. biotech spearheads European recovery The U.K.’s biotechnology landscape has witnessed an impressive surge in funding, clocking a robust £563 million ($700 million) in venture capital and public financings in the third quarter of 2023, according to Biotech Finance. This achievement marks a staggering 48% increase from the previous quarter and sets a formidable pace that is already on track […] November 17, 2023 - 4 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email